Robert C. Malenka
Director at MapLight Therapeutics, Inc. (MPLT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 8,593316,466 held (−3%) | $26.90 | $231K | -67.2% |
| Feb 24SEC | MPLTMapLight Therapeutics, Inc. | Sell | 2,195337,059 held (−1%) | $18.03 | $40K | -51.0% |
| Feb 24SEC | MPLTMapLight Therapeutics, Inc. | Sell | 10,788326,271 held (−3%) | $18.39 | $198K | -52.0% |
| Feb 24SEC | MPLTMapLight Therapeutics, Inc. | Sell | 476325,795 held (−0%) | $19.06 | $9K | -53.7% |
| Feb 24SEC | MPLTMapLight Therapeutics, Inc. | Sell | 736325,059 held (−0%) | $18.15 | $13K | -51.3% |
| Feb 18SEC | MPLTMapLight Therapeutics, Inc. | Sell | 12,116339,254 held (−3%) | $18.21 | $221K | -51.5% |
| Feb 12SEC | MPLTMapLight Therapeutics, Inc. | Sell | 6,622351,611 held (−2%) | $18.12 | $120K | -51.3% |
| Feb 12SEC | MPLTMapLight Therapeutics, Inc. | Sell | 241351,370 held (−0%) | $18.00 | $4K | -50.9% |
| Feb 4SEC | MPLTMapLight Therapeutics, Inc. | Sell | 7,039358,234 held (−2%) | $18.02 | $127K | -51.0% |
| Feb 4SEC | MPLTMapLight Therapeutics, Inc. | Sell | 1358,233 held (−0%) | $18.00 | $18 | -50.9% |
| Jan 30SEC | MPLTMapLight Therapeutics, Inc. | Sell | 5,860393,811 held (−1%) | $18.61 | $109K | -52.6% |
| Jan 30SEC | MPLTMapLight Therapeutics, Inc. | Sell | 664393,147 held (−0%) | $19.05 | $13K | -53.6% |
| Jan 30SEC | MPLTMapLight Therapeutics, Inc. | Sell | 21,262371,885 held (−5%) | $18.55 | $394K | -52.4% |
| Jan 30SEC | MPLTMapLight Therapeutics, Inc. | Sell | 6,612365,273 held (−2%) | $18.11 | $120K | -51.2% |
- Sell
Director Robert C. Malenka sold $231K of MPLT at $26.90 — pre-scheduled 10b5-1 plan sale.